Market cap
₹103 Cr
Revenue (TTM)
₹452 Cr
P/E Ratio
9.5
P/B Ratio
2.3
Div. Yield
0 %
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
103 | 16,737 | 16,561 | 7,616 | 6,242 |
Revenue (₹ Cr) |
452 | 4,537 | 3,915 | 2,966 | 1,240 |
Net Profit (₹ Cr) |
10.83 | 188.20 | 753.50 | 284.04 | 223.00 |
Net Margin (%) |
2.36 | 4.14 | 18.85 | 9.37 | 17.60 |
RoE (%) |
27.98 | 3.99 | 25.89 | 18.77 | 31.86 |
Price to Earnings |
9.51 | 88.93 | 22.13 | 26.81 | 27.99 |
Price-To-Book |
2.33 | 2.82 | 5.40 | 4.66 | 7.57 |
Income Statement (₹ Cr)
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Operating Revenue
|
452.28 | 4,537.10 | 3,914.63 | 2,966.48 | 1,239.59 |
|
Total Income
|
458.52 | 4,545.90 | 3,996.65 | 3,032.25 | 1,266.93 |
|
Total Expenditure
|
438.87 | 3,942.90 | 2,939.02 | 2,576.09 | 975.78 |
|
EBITDA
|
13.41 | 594.20 | 975.61 | 390.39 | 263.81 |
|
Depreciation
|
1.29 | 193.00 | 175.60 | 62.67 | 16.73 |
|
EBIT
|
12.12 | 401.20 | 800.01 | 327.72 | 247.08 |
|
Interest
|
4.41 | 121.90 | 14.31 | 4.85 | 1.57 |
|
Other Income
|
6.25 | 8.80 | 82.02 | 65.77 | 27.35 |
|
Exceptional Items
|
0.00 | -40.80 | -10.15 | 0.00 | 0.00 |
|
Profit before Tax
|
13.96 | 247.30 | 857.57 | 388.64 | 272.85 |
|
Provision for Tax
|
3.13 | 59.10 | 104.07 | 104.60 | 49.85 |
|
Profit after Tax
|
10.83 | 188.20 | 753.50 | 284.04 | 223.00 |
Liabilities (₹ Cr)
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
40.80 | 5,826.00 | 2,923.98 | 1,588.61 | 754.98 |
|
Minority Interest
|
0.01 | 0.00 | -1.58 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
0.61 | 3,753.30 | 75.76 | 107.26 | 16.17 |
|
Current Liabilities
|
148.25 | 728.50 | 838.24 | 556.49 | 173.98 |
|
Total Liabilities
|
189.65 | 10,189.90 | 3,830.51 | 2,911.23 | 945.13 |
Assets (₹ Cr)
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
22.77 | 8,738.00 | 1,839.04 | 470.32 | 310.99 |
|
Current Assets
|
153.92 | 1,366.70 | 1,934.86 | 1,493.03 | 607.49 |
|
Total Assets
|
189.65 | 10,189.90 | 3,830.51 | 2,911.23 | 945.13 |
|
Total Debt*
|
105.06 | 3,186.40 | 122.38 | 0.00 | 0.00 |
|
Net Current Assets
|
5.67 | 638.20 | 1,096.62 | 936.54 | 433.52 |
|
Contingent Liabilities
|
38.65 | 450.40 | 10.99 | 9.61 | 9.94 |
Cashflow (₹ Cr)
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-32.17 | 226.40 | 800.53 | 412.13 | 196.92 |
|
Cash Flow from Investing Activities
|
-29.45 | -2,909.90 | -181.14 | -276.95 | -14.45 |
|
Cash from Financing Activities
|
61.55 | 2,698.40 | -554.48 | -159.77 | -196.49 |
|
Net Cash Inflow / Outflow
|
-0.07 | 14.90 | 64.91 | -24.59 | -14.02 |
Ratios
Profitability Ratios
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
ROCE (%)
|
11.76 | 4.42 | 29.54 | 30.71 | 31.00 |
|
ROE (%)
|
27.98 | 3.99 | 25.89 | 18.77 | 31.86 |
|
ROA (%)
|
7.72 | 2.25 | 20.45 | 13.28 | 24.16 |
|
EBIT Margin (%)
|
2.68 | 8.84 | 20.44 | 11.05 | 19.93 |
|
Net Margin (%)
|
2.36 | 4.14 | 18.85 | 9.37 | 17.60 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
55.06 | 66.27 | 2.82 | 3.94 | 24.92 |
|
EBIT Growth (%)
|
175.33 | 15.99 | -5.27 | -24.30 | 103.25 |
|
Net Profit Growth (%)
|
709.72 | -42.46 | -9.02 | -22.42 | 76.99 |
|
EPS Growth (%)
|
418.34 | -85.70 | -7.37 | -22.98 | 83.44 |
|
Book Value Growth (%)
|
20.08 | 2.72 | 8.50 | 14.81 | 0.78 |
Valuation Ratios
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Price / Earnings
|
9.51 | 72.70 | 21.85 | 26.81 | 28.24 |
|
Price / Book Value
|
2.33 | 2.82 | 5.40 | 4.66 | 7.57 |
|
Dividend Yield (%)
|
0.00 | 0.23 | 2.64 | 1.69 | 0.00 |
|
EV/EBITDA
|
14.98 | 33.34 | 16.20 | 17.42 | 22.12 |
|
Market Cap (₹ Cr)
|
81.89 | 13,549.79 | 17,158.99 | 7,237.65 | 4,532.48 |
Solvency Ratios
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.52 | 0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
2.57 | 0.03 | 0.04 | -- | -- |
|
Current Ratio
|
1.04 | 1.88 | 2.31 | 2.68 | 3.49 |
|
Quick Ratio
|
0.75 | 0.83 | 1.83 | 2.06 | 3.11 |
|
Interest Coverage
|
4.16 | 3.03 | 60.93 | 81.13 | 174.68 |
Operating Efficiency Ratios
| Lykis | Zydus Wellness | Emami | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
17.07 | 8.46 | 8.77 | 8.65 | 6.10 |
|
Asset Turnover
|
3.22 | 0.54 | 1.06 | 1.39 | 1.34 |
|
Receivable days
|
51.70 | 32.76 | 38.37 | 25.54 | 23.11 |
|
Inventory Days
|
26.81 | 55.91 | 34.17 | 32.35 | 18.94 |
|
Payable days
|
19.48 | 103.68 | 146.36 | 70.92 | 36.67 |
|
Cash Conversion Cycle
|
59.03 | -15.02 | -73.82 | -13.03 | 5.38 |